TNIB Financials 07/16/2014 02:49:05 TNI BioTech,
Post# of 39
Posted On: 07/16/2014 3:49:02 AM
TNIB Financials 07/16/2014 02:49:05
TNI BioTech, Inc.
Period Ending Dec 31, 2013
Total Revenue -
Cost of Revenue -
Gross Profit -
Operating Expenses
Research and Development 22,024
Sales, General and Admin. 71,104
Non-Recurring Items -
Other 2,853
Operating Income (95,981)
Income From Continuing Operations
Add'l Income/Expense Items (8,641)
Earnings Before Interest and Tax (104,623)
Interest Expense 1,437
Earnings Before Tax (106,060)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (106,060)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (106,060)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (106,060)
TNI BioTech, Inc.
Period Ending Dec 31, 2013
Total Revenue -
Cost of Revenue -
Gross Profit -
Operating Expenses
Research and Development 22,024
Sales, General and Admin. 71,104
Non-Recurring Items -
Other 2,853
Operating Income (95,981)
Income From Continuing Operations
Add'l Income/Expense Items (8,641)
Earnings Before Interest and Tax (104,623)
Interest Expense 1,437
Earnings Before Tax (106,060)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (106,060)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (106,060)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (106,060)
(0)
(0)Biostax Corp. (BTAX) Stock Research Links
Scroll down for more posts ▼